Clinical Trials Logo

Spasticity as Sequela of Stroke clinical trials

View clinical trials related to Spasticity as Sequela of Stroke.

Filter by:

NCT ID: NCT03517319 Recruiting - Clinical trials for Spasticity as Sequela of Stroke

Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity

Start date: September 1, 2016
Phase: Phase 4
Study type: Interventional

Study Design: Randomized Single Blind Study Objective: To determine the dose relationship of DWP 450 for finger flexor spasticity Subjects: 78 patients with upper extremity spasticity after CVA Inclusion criteria: Patient who have spasticity (MAS greater than 2 in finger flexors) Methods: Patients will be randomly assigned to one of 5 groups. Gp 1: placebo, Gp 2: 15U, Gp 3: 30 U, Gp 4: 50 U, Gp 5: 75 U

NCT ID: NCT03080454 Completed - Stroke Clinical Trials

The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke

Start date: September 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate if 5 consecutive sessions of PathMaker anodal DoubleStim treatment, which combines non-invasive stimulation of the spinal cord (tsDCS- trans-spinal direct current stimulation) and of the median nerve at the peripheral wrist (pDCS-- peripheral direct current stimulation), can significantly reduce spasticity of the wrist and hand after stroke.

NCT ID: NCT03008486 Completed - Stroke Clinical Trials

Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness

Start date: January 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the effects on upper limb spasticity of soft splints worn during three weeks three hours a day by patients with stroke or disorders of consciousness.